Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02592070 · ClinicalTrials.gov registry record · NA

Activity & Cognition After Treatment for Breast Cancer

A NA study of Breast Cancer and Mild Cognitive Impairment, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT02592070 is a NA study of Breast Cancer and Mild Cognitive Impairment that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 31 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02592070, a NA study of Breast Cancer and Mild Cognitive Impairment, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

This study addresses an important public health concern; impoverished cognitive function associated with treatment of breast cancer. Due to increased awareness of breast cancer combined with advances in medical care, there are over 2.8 million women living with a history of breast cancer in the U.S. alone. Chemotherapy and adjuvant therapy to remove cancerous tissue can result in deficits in attention, speed of processing, memory, and quality of life. Physical activity has been associated with a number of health benefits for breast cancer survivors including improvements in cognitive function. However, most of the literature is cross-sectional and it is unclear whether acute (single) bouts of physical activity affect cognition and, if they do, how long this effect lasts. This study will be the first, to the investigators' knowledge, to examine the effects of an acute bout of aerobic exercise on cognitive functioning in breast cancer survivors. Specifically, the investigators will determine the effects of a 30-minute moderate intensity aerobic exercise session (treadmill walking) on immediate and one hour follow up changes in measures of processing speed, memory, and executive function. Additionally, accelerometer cut-points for physical activity intensities in breast cancer survivors will be assessed. Finally, the investigators will examine the association of cardiorespiratory fitness and physical activity with changes in cognitive function. Findings from this study will allow researchers to determine whether any acute effects of exercise on cognition are retained over time and therefore have real meaning in the context of one's daily life.

Interventions

  • BEHAVIORAL Walking

Study Locations (1)

Illinois

  • Freer Hall, University of Illinois - Urbana

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2015-07
Est. Completion 2016-04
Phase NA

What the Registry Record Tells You About NCT02592070

The ClinicalTrials.gov registry entry for NCT02592070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Walking is the first listed.

NCT02592070 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT02592070 about?

NCT02592070 is a clinical study titled "Activity & Cognition After Treatment for Breast Cancer". This study addresses an important public health concern; impoverished cognitive function associated with treatment of breast cancer. Due to increased awareness of breast cancer combined with advances in medical care, there are over 2.8 million women living with a history of breast cancer in the U.S....

What is the current status of trial NCT02592070?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2015-07. Estimated completion is 2016-04.

What conditions does trial NCT02592070 study?

This clinical trial studies the following conditions: Breast Cancer, Mild Cognitive Impairment, Physical Activity.

What interventions are being tested in trial NCT02592070?

The interventions under investigation include: Walking (BEHAVIORAL).

Who is sponsoring clinical trial NCT02592070?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02592070 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.